The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

CVS Pharmacy Inc. and the former president of Cigna Corp.'s Express Scripts asked a federal judge to amend an injunction ...

Rula Health, a behavioral health company focused on improving access to mental healthcare, today announced a collaboration with Amazon Health Services to provide more ways for Amazon customers to find ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

Also, she still views pharmacy benefit management transparency as a key concern for both major political parties, but we ...

GoodRx (NASDAQ:GDRX) is facing lawsuits from several independent pharmacies who are accusing the company of working with ...

President Donald Trump has won back the White House, and with his win, many health plans are seeing their stocks rise. | ...

The new administration is likely to pull back on Biden-era measures affecting health insurers, drug prices and public-health ...

CVS Health Corp (NYSE:CVS) reported third-quarter sales of $95.43 billion, beating the consensus of $92.75 billion. Total ...

CVS Health (CVS) stock gains as company reports better than expected Q3 2024 revenue and names former UnitedHealth (UNH) ...